image
Pieris Pharmaceuticals, Inc. PIRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.8679
-0.202 %
$ 21 M
Market Cap
-0.83
P/E
BALANCE SHEET
38.7 M ASSETS
-59.49%
Growth Rates
1Year -59.49%
3Years -28.32%
5Years -22.83%
7Years 1.41%
10Years 18.18%
11.9 M LIABILITIES
-82.35%
Growth Rates
1Year -82.35%
3Years -45.58%
5Years -34.83%
7Years 2.79%
10Years 5.94%
26.8 M EQUITY
-4.19%
Growth Rates
1Year -4.19%
3Years -4.81%
5Years -7.70%
7Years 0.85%
10Years 46.56%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Pieris Pharmaceuticals, Inc.
image
Current Assets 38.7 M
Cash & Short-Term Investments 26.4 M
Receivables 572 K
Other Current Assets 11.7 M
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 11.9 M
Accounts Payable 3.37 M
Short-Term Debt 0
Other Current Liabilities 8.55 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 17.4 38.6 117.8 70.4 62.3 74.9 37.9 29.4 29.3 18.5 3.7 6.3
Short Term Investments 9.0 20.5 0 0 41.9 53.2 34.8 0 0 0 0 0
Receivables 0.6 5.8 3.3 1.7 6.8 2.7 15.5 57 K 0 0 0.7 1.0
Inventory 0 0 0 1 0 1 0 0 (1.0) 1 72.5 K 1
Other Current Assets 11.7 8.4 13.1 7.2 8.1 9.1 3.2 3.3 1.3 1.3 0.4 0.6
Total Current Assets 38.7 73.4 127.6 75.7 115.0 135.4 89.8 32.7 31.7 19.8 4.8 7.9
PP&E 0 20.7 23.0 26.0 22.9 5.0 4.0 2.3 2.2 2.1 2.4 2.7
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 9.9 0 0 0 0 0
Other Long Term Assets 0 1.4 2.9 3.3 3.1 0.9 0.1 0.1 0.1 0 0 (2.7)
Other Assets 0 0 0 0 0 0 0 0 0 0 1 31 K
Total Assets 38.7 95.5 153.6 105.0 141.1 141.3 103.9 35.1 34.0 21.9 7.3 10.6
LIABILITIES
Accounts Payable 3.4 4.2 8.6 1.8 5.8 3.4 2.5 2.4 1.1 1.3 0.3 0.8
Short Term Debt 0 0.9 1.0 1.0 0.7 0 0 0 0 1.3 0.2 0
Other Current Liabilities 8.6 10.7 15.8 6.6 8.7 8.7 5.7 5.5 1.6 1.0 0.7 8.4
Total Current Liabilities 11.9 36.6 50.6 22.1 27.0 48.1 45.8 8.4 2.8 3.5 1.8 9.3
Long Term Debt 0 12.2 13.8 15.9 15.5 0 0 0 0 0 4.5 0
Deferred Tax Income 0 (18.7) (38.4) 0 (47.3) 0 0 0 0 0 0 0
Other Liabilities 0 0 0 6 K 0 27 K 37 K 1.5 23.9 K 0.3 0.4 0
Total Liabilities 11.9 67.6 102.8 74.0 89.7 101.4 92.4 9.8 2.8 3.9 6.7 9.3
EQUITY
Common Stock 98 K 74 K 72 K 56 K 55 K 54 K 45 K 43.1 K 39.8 K 29.3 K 11.8 K 53.9 K
Retained Earnings (315.0) (290.4) (257.1) (211.4) (174.2) (147.1) (120.3) (102.7) (79.9) (65.8) (56.0) (56.0)
Other Accumulative Comprehensive Income/Loss 28 K (0.3) 0.8 (0.3) (2.0) (3.0) (4.7) (1.5) (1.3) (0.8) (1.0) 0
Total Equity 26.8 27.9 50.8 31.0 51.4 39.9 11.5 25.2 31.1 18.0 0.6 0.5
Total Liabilities and Equity 38.7 95.5 153.6 105.0 141.1 141.3 103.9 35.1 34.0 21.9 7.3 0
SHARES OUTSTANDING
Common Shares Outstanding 1.1 0.9 0.8 0.7 0.6 0.7 0.5 0.5 0.4 0.5 0.5 60 K